Halaman 2 - Imunoterapi untuk kanker ginjal Dokter Terbaik - TOP-39 dokter

Lektor Kepala Nail Paksoy berspesialisasi dalam imunoterapi untuk kanker ginjal di Rumah Sakit Medipol Bahçelievler, dengan penelitian ekstensif dalam karsinoma sel ginjal.

• Bersertifikasi Dewan ESMO dalam Onkologi Medis
• Menerbitkan penelitian tentang hasil karsinoma sel ginjal metastatik
• Berpartisipasi dalam uji klinis internasional untuk terapi kanker baru

Dr. Alemdar berspesialisasi dalam onkologi medis dengan pelatihan ekstensif di Universitas Akdeniz, berfokus pada imunoterapi kanker ginjal di Medical Park Antalya.

• Bersertifikat dalam Onkologi Medis sejak 2018
• Pengalaman lebih dari 7 tahun di bidang onkologi
• Bekerja di kompleks rumah sakit terkemuka di Antalya

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Profesor Onkologi Medis dengan pengalaman lebih dari 20 tahun – Dr. Cicin berspesialisasi dalam perawatan kanker ginjal stadium lanjut di Rumah Sakit Liv Universitas İstinye Topkapı.

• Menyelesaikan program Fellowship (Pelatihan Subspesialisasi) dalam Onkologi Medis di Universitas Trakya
• Profesor Madya dan kemudian menjadi Profesor di Fakultas Kedokteran Universitas Trakya
• Pengalaman luas dalam imunoterapi dan terapi target untuk kanker ginjal
• Anggota Asosiasi Onkologi Medis Turki

Profesor Madya Atakan Topcu berspesialisasi dalam terapi bertarget dan imunoterapi di Rumah Sakit Distrik Medipol Acibadem.

• Telah menerbitkan lebih dari 50 artikel ilmiah mengenai topik onkologi
• Anggota Masyarakat Eropa untuk Onkologi Medis (ESMO)
• Keahlian dalam malnutrisi terkait kanker dan onkologi geriatri
• Pelatihan subspesialisasi (Fellowship) dalam onkologi medis di Universitas Bezmialem Vakıf

Profesor Madya Onkologi Medis di İstinye University Liv Hospital Topkapı, berspesialisasi dalam imunoterapi untuk kanker ginjal.

• Anggota American Society of Clinical Oncology (ASCO)
• Telah memublikasikan beberapa artikel yang ditinjau sejawat mengenai hasil pengobatan kanker
• Koordinator Pendidikan untuk Sub-Bidang Onkologi Medis
• Pengalaman luas dalam onkologi klinis dan akademis

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Sridhar P.S. berspesialisasi dalam radioterapi dengan pelatihan ekstensif di bidang onkologi, termasuk imunoterapi untuk kanker ginjal di HCG Manavata Cancer Centre.

• Tersertifikasi dewan dalam radioterapi dengan pengalaman lebih dari 20 tahun
• Anggota Association of Radiation Oncology of India
• Spesialisasi dalam neuro-onkologi dan onkologi hipertermia
• Menempuh pendidikan di Banaras Hindu University dan Mysore University

Dr. Raj Nagarkar telah melakukan 50.000+ operasi kanker dengan fokus pada peningkatan kualitas hidup pasien. Beliau berspesialisasi dalam Bedah Onkologi Payudara dan Toraks di HCG Manavata Cancer Centre.

• Menempuh pendidikan di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• 19 tahun pengalaman dalam bedah onkologi
• Terlibat dalam 200+ uji klinis fase 1-3
• Profesor untuk DNB Superspecialty Bedah Onkologi dan Bedah Payudara
• Berbagai publikasi internasional dan nasional

Dr. Shaunak Valame berspesialisasi dalam imunoterapi untuk kanker ginjal, dengan fokus kuat pada terapi target dan penelitian molekuler.

• Menyelesaikan DNB dalam Onkologi Medis dari Indraprastha Apollo Hospital
• Mempresentasikan penelitian tentang kanker lambung di ASCO Gastrointestinal Symposium
• Keahlian dalam dasar molekuler kanker dan terapi target
• Residensi Senior di Penyakit Dalam di Shyam Shah Medical College

Dr. Lalit Banswal berfokus pada Bedah Kanker Invasif Minimal dengan hasil yang sangat baik di HCG Manavata Cancer Centre.

• Melakukan 10.000+ operasi besar selama lebih dari 10 tahun
• Fellowship dalam Onkologi Bedah di Tata Medical Centre, Kolkata
• Fokus khusus pada Kanker Gastrointestinal
• Co-principal Investigator dalam berbagai proyek penelitian asli

Dr. Ahmer Arif Shaikh berspesialisasi dalam onkologi bedah dengan fokus pada kanker mulut dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 3 tahun pengalaman dalam onkologi bedah
• Keahlian dalam preservasi organ dan rehabilitasi fungsional
• Mahir dalam bedah maksilofasial serta kepala & leher utama
• Terlatih melalui Fellowship dalam Onkologi Bedah Kepala & Leher
• Peneliti aktif dengan berbagai publikasi

Spesialisasi dalam imunoterapi untuk kanker ginjal – Dr. Kate mempresentasikan penelitiannya tentang kanker paru-paru di Konferensi Dunia tentang Kanker Paru-paru.

• Terlatih dalam onkologi medis di Tata Memorial Hospital
• Ahli dalam kanker paru-paru, payudara, dan genitourinari
• Anggota ASCO, ESMO, dan perkumpulan onkologi terkemuka lainnya
• Berfokus pada imunoterapi dan terapi metronomik untuk kanker stadium lanjut

Menangani lebih dari 30.000 pemindaian PET dan 1.000 pasien kanker tiroid – Dr. Borde berspesialisasi dalam terapi kedokteran nuklir tingkat lanjut di HCG Manavata Cancer Centre.

• 12 tahun pengalaman dalam kedokteran nuklir dan onkologi
• Mahir dalam terapi radioiodin dan Lu-177 RN
• Penelitian yang dipublikasikan di berbagai jurnal medis
• Berpengalaman dalam semua jenis pemindaian nuklir dan pencitraan PET-CT